These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28381845)

  • 1. Autoimmunity as a Potential Cause of Post-Infectious Gut Dysmotility: A Longitudinal Observation.
    Rezaie A; Pimentel M; Cohen E
    Am J Gastroenterol; 2017 Apr; 112(4):656-657. PubMed ID: 28381845
    [No Abstract]   [Full Text] [Related]  

  • 2. A definitive blood test for post-infectious irritable bowel syndrome?
    Barlow GM; Rezaie A; Lin E; Pimentel M
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1197-1199. PubMed ID: 27682513
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostics: Filling in the missing pieces.
    Katsnelson A
    Nature; 2016 May; 533(7603):S110-1. PubMed ID: 27191489
    [No Abstract]   [Full Text] [Related]  

  • 4. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
    Morales W; Triantafyllou K; Parodi G; Weitsman S; Park SC; Rezaie A; Pichetshote N; Lin E; Pimentel M
    Neurogastroenterol Motil; 2020 Oct; 32(10):e13875. PubMed ID: 32436301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
    Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
    PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
    Pimentel M; Morales W; Pokkunuri V; Brikos C; Kim SM; Kim SE; Triantafyllou K; Weitsman S; Marsh Z; Marsh E; Chua KS; Srinivasan S; Barlow GM; Chang C
    Dig Dis Sci; 2015 May; 60(5):1195-205. PubMed ID: 25424202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.
    Morales W; Rezaie A; Barlow G; Pimentel M
    Dig Dis Sci; 2019 Nov; 64(11):3115-3121. PubMed ID: 31152332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.
    Pike BL; Paden KA; Alcala AN; Jaep KM; Gormley RP; Maue AC; Christmann BS; Elson CO; Riddle MS; Porter CK
    J Travel Med; 2015; 22(4):242-50. PubMed ID: 26058758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin.
    Bonfrate L; Di Ciaula A; Portincasa P
    Eur J Clin Invest; 2022 Jan; 52(1):e13702. PubMed ID: 34738648
    [No Abstract]   [Full Text] [Related]  

  • 12. A 51-year-old with irritable bowel syndrome: test or treat for bacterial overgrowth?
    Quigley EM
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1140-3. PubMed ID: 17916541
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postinfectious irritable bowel syndrome].
    Döbrönte Z; Lakner L; Sarang K
    Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection, inflammation, and the irritable bowel syndrome.
    Spiller R; Garsed K
    Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious disease: Something in the water.
    Gupta S
    Nature; 2016 May; 533(7603):S114-5. PubMed ID: 27191491
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-infectious irritable bowel syndrome].
    Pallotti F; Fogacci E; Frisoni C; Serra M; Bellacosa L; Carini G; Cremon C; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Clin Ter; 2011; 162(2):157-61. PubMed ID: 21533323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.
    Collins SM; Barbara G
    Gut; 2004 Aug; 53(8):1068-9. PubMed ID: 15247169
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-term functional consequences of acute infectious diarrhea.
    Cocciolillo S; Collins SM
    Curr Opin Gastroenterol; 2016 Jan; 32(1):1-6. PubMed ID: 26628101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-infectious irritable bowel syndrome in the community: a prospective cohort study].
    Ryu HS; Choi SC
    Korean J Gastroenterol; 2012 Jul; 60(1):1-2. PubMed ID: 23008846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.